
Shantell Laketa Heiber
Examiner (ID: 4200, Phone: (571)272-0886 , Office: P/2641 )
| Most Active Art Unit | 2645 |
| Art Unit(s) | 2641, 2644, 2645, 2617 |
| Total Applications | 943 |
| Issued Applications | 655 |
| Pending Applications | 110 |
| Abandoned Applications | 212 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6692229
[patent_doc_number] => 20030039661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Methods, compositions and kits for preserving antigenicity'
[patent_app_type] => new
[patent_app_number] => 10/087607
[patent_app_country] => US
[patent_app_date] => 2002-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 43269
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20030039661.pdf
[firstpage_image] =>[orig_patent_app_number] => 10087607
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/087607 | Methods, compositions and kits for preserving antigenicity | Feb 28, 2002 | Abandoned |
Array
(
[id] => 957430
[patent_doc_number] => RE038824
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2005-10-11
[patent_title] => 'Antibodies against human herpes virus-6(HHV-6) and method of use'
[patent_app_type] => reissue
[patent_app_number] => 10/087882
[patent_app_country] => US
[patent_app_date] => 2002-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 27
[patent_no_of_words] => 9040
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/038/RE038824.pdf
[firstpage_image] =>[orig_patent_app_number] => 10087882
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/087882 | Antibodies against human herpes virus-6(HHV-6) and method of use | Feb 28, 2002 | Issued |
Array
(
[id] => 6774110
[patent_doc_number] => 20030017448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Method of prophylaxis and treatment of porcine reproductive and respiratory syndrome'
[patent_app_type] => new
[patent_app_number] => 10/081753
[patent_app_country] => US
[patent_app_date] => 2002-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7256
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017448.pdf
[firstpage_image] =>[orig_patent_app_number] => 10081753
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/081753 | Method of prophylaxis and treatment of porcine reproductive and respiratory syndrome | Feb 21, 2002 | Abandoned |
Array
(
[id] => 6740334
[patent_doc_number] => 20030157703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Recombinant herpesvirus of turkeys and use thereof'
[patent_app_type] => new
[patent_app_number] => 10/059152
[patent_app_country] => US
[patent_app_date] => 2002-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6462
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157703.pdf
[firstpage_image] =>[orig_patent_app_number] => 10059152
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/059152 | Recombinant herpesvirus of turkeys and use thereof | Jan 30, 2002 | Issued |
| 10/048016 | Virus-like particles devoid of HPV-L1 type-specific B-cell or antibody epitopes as carriers of peptides for introduction into cells | Jan 27, 2002 | Abandoned |
Array
(
[id] => 6545929
[patent_doc_number] => 20020110866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses'
[patent_app_type] => new
[patent_app_number] => 10/056360
[patent_app_country] => US
[patent_app_date] => 2002-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 3344
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20020110866.pdf
[firstpage_image] =>[orig_patent_app_number] => 10056360
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/056360 | Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses | Jan 22, 2002 | Issued |
Array
(
[id] => 6545917
[patent_doc_number] => 20020110865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses'
[patent_app_type] => new
[patent_app_number] => 10/056359
[patent_app_country] => US
[patent_app_date] => 2002-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 3387
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20020110865.pdf
[firstpage_image] =>[orig_patent_app_number] => 10056359
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/056359 | Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses | Jan 22, 2002 | Issued |
Array
(
[id] => 6611819
[patent_doc_number] => 20020064534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Herpesvirus preparations and their uses'
[patent_app_type] => new
[patent_app_number] => 10/055271
[patent_app_country] => US
[patent_app_date] => 2002-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4258
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20020064534.pdf
[firstpage_image] =>[orig_patent_app_number] => 10055271
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/055271 | Herpesvirus preparations and their uses | Jan 21, 2002 | Abandoned |
Array
(
[id] => 1114822
[patent_doc_number] => 06800289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-10-05
[patent_title] => 'Strain of the western equine encephalitis virus'
[patent_app_type] => B2
[patent_app_number] => 10/023649
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 27007
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/800/06800289.pdf
[firstpage_image] =>[orig_patent_app_number] => 10023649
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/023649 | Strain of the western equine encephalitis virus | Dec 20, 2001 | Issued |
Array
(
[id] => 1195848
[patent_doc_number] => 06726912
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-27
[patent_title] => 'Papillomavirus polyprotein constructs'
[patent_app_type] => B1
[patent_app_number] => 10/011749
[patent_app_country] => US
[patent_app_date] => 2001-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20697
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/726/06726912.pdf
[firstpage_image] =>[orig_patent_app_number] => 10011749
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/011749 | Papillomavirus polyprotein constructs | Dec 10, 2001 | Issued |
Array
(
[id] => 503934
[patent_doc_number] => 07202034
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-10
[patent_title] => 'Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses'
[patent_app_type] => utility
[patent_app_number] => 10/433936
[patent_app_country] => US
[patent_app_date] => 2001-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 26307
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/202/07202034.pdf
[firstpage_image] =>[orig_patent_app_number] => 10433936
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/433936 | Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses | Dec 6, 2001 | Issued |
Array
(
[id] => 6175622
[patent_doc_number] => 20020155432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Genetically engineered herpes virus for the treatment of cardiovascular disease'
[patent_app_type] => new
[patent_app_number] => 09/995475
[patent_app_country] => US
[patent_app_date] => 2001-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35790
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20020155432.pdf
[firstpage_image] =>[orig_patent_app_number] => 09995475
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/995475 | Genetically engineered herpes virus for the treatment of cardiovascular disease | Nov 27, 2001 | Issued |
Array
(
[id] => 1353255
[patent_doc_number] => RE038097
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2003-04-29
[patent_title] => 'Chemical vapor deposition system with a plasma chamber having separate process gas and cleaning gas injection ports'
[patent_app_type] => E1
[patent_app_number] => 09/989106
[patent_app_country] => US
[patent_app_date] => 2001-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3312
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/038/RE038097.pdf
[firstpage_image] =>[orig_patent_app_number] => 09989106
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/989106 | Chemical vapor deposition system with a plasma chamber having separate process gas and cleaning gas injection ports | Nov 20, 2001 | Issued |
Array
(
[id] => 6015577
[patent_doc_number] => 20020102536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Preparation of human or animal herpesviruses'
[patent_app_type] => new
[patent_app_number] => 09/990141
[patent_app_country] => US
[patent_app_date] => 2001-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3936
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20020102536.pdf
[firstpage_image] =>[orig_patent_app_number] => 09990141
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/990141 | Preparation of human or animal herpesviruses | Nov 19, 2001 | Abandoned |
Array
(
[id] => 528081
[patent_doc_number] => 07179471
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-20
[patent_title] => 'Materials and methods relating to fusion proteins an immune response'
[patent_app_type] => utility
[patent_app_number] => 10/416290
[patent_app_country] => US
[patent_app_date] => 2001-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 15145
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/179/07179471.pdf
[firstpage_image] =>[orig_patent_app_number] => 10416290
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/416290 | Materials and methods relating to fusion proteins an immune response | Nov 19, 2001 | Issued |
Array
(
[id] => 7195429
[patent_doc_number] => 20050164163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'ASSAY FOR SCREENING FOR AN ANTI-VIRAL AGENT'
[patent_app_type] => utility
[patent_app_number] => 09/988851
[patent_app_country] => US
[patent_app_date] => 2001-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 13203
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164163.pdf
[firstpage_image] =>[orig_patent_app_number] => 09988851
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/988851 | ASSAY FOR SCREENING FOR AN ANTI-VIRAL AGENT | Nov 18, 2001 | Abandoned |
Array
(
[id] => 6305373
[patent_doc_number] => 20020094337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-18
[patent_title] => 'Prevention of recurrent viral disease'
[patent_app_type] => new
[patent_app_number] => 09/992453
[patent_app_country] => US
[patent_app_date] => 2001-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8584
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20020094337.pdf
[firstpage_image] =>[orig_patent_app_number] => 09992453
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/992453 | Prevention of recurrent viral disease | Nov 15, 2001 | Abandoned |
Array
(
[id] => 1088312
[patent_doc_number] => 06827933
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-12-07
[patent_title] => 'Immunogenic compositions of human papillomavirus and sera produced therefrom'
[patent_app_type] => B2
[patent_app_number] => 09/987557
[patent_app_country] => US
[patent_app_date] => 2001-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9098
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/827/06827933.pdf
[firstpage_image] =>[orig_patent_app_number] => 09987557
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/987557 | Immunogenic compositions of human papillomavirus and sera produced therefrom | Nov 14, 2001 | Issued |
Array
(
[id] => 6744623
[patent_doc_number] => 20030021806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Papilloma virus capsomere vaccine formulations and method of use'
[patent_app_type] => new
[patent_app_number] => 09/986118
[patent_app_country] => US
[patent_app_date] => 2001-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7628
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20030021806.pdf
[firstpage_image] =>[orig_patent_app_number] => 09986118
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/986118 | Papilloma truncated L1 protein and fusion protein constructs | Nov 6, 2001 | Issued |
Array
(
[id] => 1188742
[patent_doc_number] => 06733973
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-05-11
[patent_title] => 'Diagnostic reagents for human cytomegalovirus and methods of use'
[patent_app_type] => B2
[patent_app_number] => 09/984365
[patent_app_country] => US
[patent_app_date] => 2001-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 36
[patent_no_of_words] => 15682
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/733/06733973.pdf
[firstpage_image] =>[orig_patent_app_number] => 09984365
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/984365 | Diagnostic reagents for human cytomegalovirus and methods of use | Oct 29, 2001 | Issued |